Prosecution Insights
Prosecution Insights
8 pending office actions • 4 clients • 7 examiners • 7 art units • 0 of 8 (0%) have an AI response strategy ready • 18 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 6 (75%) |
| §112 only | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHEELER, THURMAN MICHAEL | 2 | 45.4% | +23.6% |
| WEBB, WALTER E | 1 | 46.4% | +18.6% |
| CRUICKSHANK, DESTINY JOI | 1 | 23.8% | +22.1% |
| MI, QIUWEN | 1 | 68.2% | +49.9% |
| CALEY, MICHAEL H | 1 | 64.8% | +13.6% |
| MACH, ANDRE | 1 | 42.9% | +54.4% |
| KIM, DANIELLE A | 1 | 37.2% | +58.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18132589 | Drug Delivery Cannula with Continuous Glucose Monitoring Capability | CRUICKSHANK, DESTINY JOI | 33d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765283 | Fibre Optic Connector | CALEY, MICHAEL H | 330d overdue |
| 17967267 | Microemulsion Delivery Systems for A Female Hormone Blend with Alcohol-Soluble Species Including Nonderivatized Hormones | WHEELER, THURMAN MICHAEL | 145d overdue |
| 18020323 | Bee Product Extracts, Methods of Production, and Uses Thereof | MI, QIUWEN | 51d overdue |
| 17672894 | Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones | WHEELER, THURMAN MICHAEL | 38d overdue |
| 18615236 | MICROEMULSION DELIVERY SYSTEMS INCORPORATED INTO GUMMY CONFECTIONS | WEBB, WALTER E | 5d overdue |
| 17672988 | MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES | KIM, DANIELLE A | 23d |
| 18132589 | Drug Delivery Cannula with Continuous Glucose Monitoring Capability | CRUICKSHANK, DESTINY JOI | 33d |
| 17707067 | Self-Microemulsifying Multi-Deliverable Systems | MACH, ANDRE | 34d |
| Client (Assignee) | Pending OAs |
|---|---|
| Quicksilver Scientific, Inc. | 5 |
| Pacific Diabetes Technologies, Inc. | 1 |
| Quantum Technologies Limited | 1 |
| Ridgemount Technologies Limited | 1 |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| 1612 | 1 |
| 3791 | 1 |
| 1655 | 1 |
| 2871 | 1 |
| 1615 | 1 |
| 1613 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18615236 | MICROEMULSION DELIVERY SYSTEMS INCORPORATED INTO GUMMY CONFECTIONS | Quicksilver Scientific, Inc. | WEBB, WALTER E | 1612 | §103 | Non-Final OA | 5d overdue | Pending | Mar 25, 2024 |
| 18132589 | Drug Delivery Cannula with Continuous Glucose Monitoring Capability | Pacific Diabetes Technologies, Inc. | CRUICKSHANK, DESTINY JOI | 3791 | §103 | Final Rejection | 33d | Pending | Apr 10, 2023 |
| 18020323 | Bee Product Extracts, Methods of Production, and Uses Thereof | Quantum Technologies Limited | MI, QIUWEN | 1655 | §112 | Non-Final OA | 51d overdue | Pending | Feb 08, 2023 |
| 17967267 | Microemulsion Delivery Systems for A Female Hormone Blend with Alcohol-Soluble Species Including Nonderivatized Hormones | Quicksilver Scientific, Inc. | WHEELER, THURMAN MICHAEL | 1619 | §103 | Non-Final OA | 145d overdue | Pending | Oct 17, 2022 |
| 17765283 | Fibre Optic Connector | Ridgemount Technologies Limited | CALEY, MICHAEL H | 2871 | §103 | Final Rejection | 330d overdue | Pending | Mar 30, 2022 |
| 17707067 | Self-Microemulsifying Multi-Deliverable Systems | Quicksilver Scientific, Inc. | MACH, ANDRE | 1615 | §103 | Non-Final OA | 34d | Pending | Mar 29, 2022 |
| 17672894 | Microemulsion Delivery Systems for Alcohol-Soluble Species Including Nonderivatized Hormones | Quicksilver Scientific, Inc. | WHEELER, THURMAN MICHAEL | 1619 | §112 | Non-Final OA | 38d overdue | Pending | Feb 16, 2022 |
| 17672988 | MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES | Quicksilver Scientific, Inc. | KIM, DANIELLE A | 1613 | §103 | Final Rejection | 23d | Pending | Feb 16, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial